Merck has announced that its chairman Richard Clark will retire from the company and the board of directors.
The news comes after Clark stepped down from his role as president and CEO, handing over to Kenneth Frazier. In his stead, Frazier will also become chairman.
Clark said: "I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family.”
New appointments at biopharma and equipment companies also feature in this week's column.
Plus other people on the move in the pharma industry in this week's column.
People are on the move at Baxter, Merck & Co., Johnson & Johnson, and elsewhere in this...
Twin changes at AstraZeneca's MedImmune kick off this week's gallery, as well as jobs news from Europe
UCB has more than drugs in its 2015 pipeline, while BUPA and biotechs hire new recruits.